Intellia Therapeutics in the NEWS
February 26, 2026, Intellia Therapeutics, Inc. (NTLA), reported business updates and financial results for the fourth quarter and year ended December 31, 2025.
From Intellia Therapeutics
Intellia President and Chief Executive Officer John Leonard, M.D, said, “2025 was a time of accomplishment and resiliency for Intellia . . .
This content is for paid subscribers.
Today’s Highlights
February 26, 2026
